Science News
from research organizations

Inadequately managed allergies cause significant economic burden in Europe

Date:
August 4, 2014
Source:
Wiley
Summary:
New research in Europe indicates that avoidable indirect costs per patient insufficiently treated for allergy equal 2,405.00 Euros per year due to absence from work and reduced working capacity. On the other hand, appropriate therapy is available at an average cost of 125 Euros per patient annually, which represents only 5 percent of the cost of untreated disease.
Share:
       
FULL STORY

New research indicates that avoidable indirect costs per patient insufficiently treated for allergy equal 2,405.00 Euros per year due to absence from work and reduced working capacity.

On the other hand, appropriate therapy is available at an average cost of 125 Euros per patient annually, which represents only 5% of the cost of untreated disease.

"Between 55 and 151 billion Euros EU wide could be saved every year by better management of allergies," said Dr. Torsten Zuberbier, lead author of the Allergy study.


Story Source:

The above post is reprinted from materials provided by Wiley. Note: Materials may be edited for content and length.


Journal Reference:

  1. T. Zuberbier, J. Lötvall, S. Simoens, S. V. Subramanian, M. K. Church. Economic burden of inadequate management of allergic diseases in the European Union: a GA2LEN review. Allergy, 2014; DOI: 10.1111/all.12470

Cite This Page:

Wiley. "Inadequately managed allergies cause significant economic burden in Europe." ScienceDaily. ScienceDaily, 4 August 2014. <www.sciencedaily.com/releases/2014/08/140804123356.htm>.
Wiley. (2014, August 4). Inadequately managed allergies cause significant economic burden in Europe. ScienceDaily. Retrieved June 29, 2015 from www.sciencedaily.com/releases/2014/08/140804123356.htm
Wiley. "Inadequately managed allergies cause significant economic burden in Europe." ScienceDaily. www.sciencedaily.com/releases/2014/08/140804123356.htm (accessed June 29, 2015).

Share This Page: